These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33336609)

  • 1. Progress in the development of stabilization strategies for nanocrystal preparations.
    Li J; Wang Z; Zhang H; Gao J; Zheng A
    Drug Deliv; 2021 Dec; 28(1):19-36. PubMed ID: 33336609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Strategies for Stabilizing Drug Nanocrystals.
    Yang H; Kim H; Jung S; Seo H; Nida SK; Yoo SY; Lee J
    Curr Pharm Des; 2018; 24(21):2362-2374. PubMed ID: 29766785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.
    Peltonen L; Strachan C
    Molecules; 2015 Dec; 20(12):22286-300. PubMed ID: 26703528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active freeze drying for production of nanocrystal-based powder: A pilot study.
    Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
    Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Vitrification of Stabilizers/Matrix Formers for the Redispersibility of Drug Nanocrystals After Solidification: a Case Study.
    Yue P; Xiao M; Xie Y; Ma Y; Guan Y; Wu Z; Hu P; Wang Y
    AAPS PharmSciTech; 2016 Dec; 17(6):1274-1284. PubMed ID: 26689405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property.
    Yue PF; Li Y; Wan J; Yang M; Zhu WF; Wang CH
    Int J Pharm; 2013 Sep; 454(1):269-77. PubMed ID: 23830942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
    Kayaert P; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization.
    Gol D; Thakkar S; Misra M
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1458-1466. PubMed ID: 29619857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.
    Peltonen L; Hirvonen J
    J Pharm Pharmacol; 2010 Nov; 62(11):1569-79. PubMed ID: 21039542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization.
    Huang F; Jiang X; Sallam MA; Zhang X; He W
    AAPS PharmSciTech; 2022 Feb; 23(3):76. PubMed ID: 35178657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of solidification stress on the redispersibility of solid nanocrystals loaded with harmine.
    Yue P; Wang C; Dan J; Liu W; Wu Z; Yang M
    Int J Pharm; 2015 Mar; 480(1-2):107-15. PubMed ID: 25617675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on formability of solid nanosuspensions during solidification: II novel roles of freezing stress and cryoprotectant property.
    Yue PF; Li G; Dan JX; Wu ZF; Wang CH; Zhu WF; Yang M
    Int J Pharm; 2014 Nov; 475(1-2):35-48. PubMed ID: 25158243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
    Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of effect of variables on particle size of telmisartan nanosuspensions using box-Behnken design.
    Rao MR; Bajaj A
    Drug Res (Stuttg); 2014 Dec; 64(12):663-7. PubMed ID: 24549965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.
    Tuomela A; Laaksonen T; Laru J; Antikainen O; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2015 May; 485(1-2):77-86. PubMed ID: 25746735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.
    Yue PF; Wan J; Wang Y; Li Y; Ma YQ; Yang M; Hu PY; Yuan HL; Wang CH
    Int J Pharm; 2013 Feb; 443(1-2):279-87. PubMed ID: 23291447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals.
    Soisuwan S; Teeranachaideekul V; Wongrakpanich A; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2019 Apr; 137():68-76. PubMed ID: 30769087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
    Yuminoki K; Seko F; Horii S; Takeuchi H; Teramoto K; Nakada Y; Hashimoto N
    J Pharm Sci; 2014 Nov; 103(11):3772-3781. PubMed ID: 25209659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
    Leone F; Cavalli R
    Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.